Differential expression of ADAMTS-1, -4, -5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis

Journal of Autoimmunity

Volumn 26, Issue 1, 2006, Pages 16-23

  Cross, A K ^a,b   Haddock, G ^a,b   Surr, J ^a,b   Plumb, J ^a   Bunning, R A D ^a   Buttle, D J ^b   Woodroofe, M N ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

ADAMTS; Brain; EAE; Extracellular matrix; Inflammation

Indexed keywords

DISINTEGRIN; METALLOPROTEINASE; PROTEIN ADAMTS 1; PROTEIN ADAMTS 4; PROTEIN ADAMTS 5; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; IMMUNOCYTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; WESTERN BLOTTING;

ACUTE DISEASE; ADAM PROTEINS; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 31344448323     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2005.09.026     Document Type: Article

References (46)

1. M.N. Pangalos, J. Shioi, S. Efthimiopoulos, A. Wu, and N.K. Robakis Characterization of appican, the chondroitin sulfate proteoglycan form of the Alzheimer amyloid precursor protein Neurodegeneration 5 1996 445 451
2. C.E. Bandtlow, and D.R. Zimmermann Proteoglycans in the developing brain: new conceptual insights for old proteins Physiol Rev 80 2000 1267 1290
3. U. Novak, and A.H. Kaye Extracellular matrix and the brain: components and function J Clin Neurosci 7 2000 280 290
4. Y. Yamaguchi Lecticans: organizers of the brain extracellular matrix Cell Mol Life Sci 57 2000 276 289
5. M. Inatani, M. Honjo, Y. Otori, A. Oohira, N. Kido, and Y. Tano Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture Invest Ophthalmol Vis Sci 42 2001 1930 1938
6. C.A. Krekoski, D. Neubauer, J. Zuo, and D. Muir Axonal regeneration into acellular nerve grafts is enhanced by degradation of chondroitin sulfate proteoglycan J Neurosci 21 2001 6206 6213
7. S. Kurazono, M. Okamoto, S. Mori, and H. Matsui Recombinant core protein fragment of phosphocan, a brain specific chondroitin sulfate proteoglycan, promote excitotoxic cell death of cultured rat hippocampal neurons Neurosci Lett 304 2001 169 172
8. R.A. Sobel, and A.S. Ahmed White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis J Neuropathol Exp Neurol 60 2001 1198 1207
9. R.A. Asher, D.A. Morgenstern, M.C. Shearer, K.H. Adcock, P. Pesheva, and J.W. Fawcett Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells J Neurosci 22 2002 2225 2236
10. J. Zuo, D. Neubauer, J. Graham, C.A. Krekoski, T.A. Ferguson, and D. Muir Regeneration of axons after nerve transection repair is enhanced by degradation of chondroitin sulfate proteoglycan Exp Neurol 176 2002 221 228
11. M.E. Behi, S. Dubucquoi, D. Lefranc, H. Zephir, J. De Seze, and P. Vermersch New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis Immunol Lett 96 1 2005 11 26
12. H.-P. Hartung, and B.C. Kieseir The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system J Neuroimmunol 107 2000 140 147
13. R.L.P. Lindberg, C.J.A. De Groot, L. Montagne, P. Freitag, P. van der Valk, and L. Kappos The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis Brain 124 2001 1743 1753
14. E.H. Lo, X. Wang, and M.L. Cuzner Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases J Neurosci Res 69 2002 1 9
15. T. Teesalu, A.E. Hinkkanen, and A. Vaheri Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice Am J Pathol 159 6 2001 2227 2237
16. G.A. Rosenberg Matrix metalloproteinases in neuroinflammation Glia 39 2002 279 291
17. U. Novak ADAM proteins in the brain J Clin Neurosci 11 3 2004 227 235
18. B.L. Tang ADAMTS: a novel family of extracellular matrix proteases Int J Biochem Cell Biol 33 2001 33 44
19. S. Porter, I.M. Clark, L. Kevorkian, and D.R. Edwards The ADAMTS metalloproteinases Biochem J 386 2005 15 27
20. K. Kuno, N. Kanada, E. Nakashima, F. Fujiki, F. Ichimura, and K. Matsushima Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene J Biol Chem 272 1997 556 562
21. I. Abbaszzade, R.Q. Liu, F. Yang, S.A. Rosenfield, O.H. Ross, and J.R. Link Cloning and characterisation of ADAMTS-11, an aggrecanase from the ADAMTS family J Biol Chem 274 1999 23443 23450
22. K. Satoh, N. Suzuki, and H. Yokota ADAMTS-4 (a disintegrin and metalloproteinase with thrombospondin motifs) is transcriptionally induced in beta-amyloid treated astrocytes Neurosci Lett 289 2000 177 180
23. W. Yuan, R.T. Matthews, J.D. Sandy, and P.E. Gottschall Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats Neuroscience 114 2002 1091 1101
24. A.J. Barrett, N.D. Rawlings, and E.A. O'Brien The MEROPS database as a protease information system J Struct Biol 134 2001 95 102
25. F. Vazquez, G. Hastings, M.-A. Ortega, T.F. Lane, S. Oikemus, and M. Lombardo METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity J Biol Chem 274 1999 23349 23357
26. L.A. Collins-Racie, C.R. Flannery, W. Zeng, C. Corcoran, B. Annis-Freeman, and M.J. Agostino ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage Matrix Biol 23 4 2004 219 230
27. M.N. Vankemmelbeke, G.C. Jones, C. Fowles, M.Z. Ilic, C.J. Handley, and A.J. Day Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters Eur J Biochem 270 2003 2394 2403
28. R.P.T. Somerville, J.M. Longpre, K.A. Jungers, J.M. Engle, M. Ross, and S. Evanko Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1 J Biol Chem 278 2003 9503 9513
29. S. Cal, A.J. Obaya, M. Llamazares, C. Garabaya, V. Quesada, and C. Lopez-Otin Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thronbospondin-1 domains Gene 283 2002 49 62
30. J.D. Sandy, J. Westling, R.D. Kenagy, M.L. Iruela-Arispe, C. Verscharen, and J.C. Rodriguez-Mazaneque Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4 J Biol Chem 276 2001 13372 13378
31. R.T. Matthews, S.C. Gary, C. Zerillo, M. Pratta, K. Solomon, and E.C. Arner Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member J Biol Chem 275 2000 22695 22703
32. M. Kashiwagi, M. Tortorella, H. Nagase, and K. Brew TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase-2 (ADAM-TS5) J Biol Chem 276 2001 12501 12504
33. K. Kuno, and K. Matsushima ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type 1 motifs and its spacing region J Biol Chem 273 1998 13912 13917
34. G. Hashimoto, T. Aoki, H. Nakamura, K. Tanzawa, and Y. Okada Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4) FEBS Lett 494 2001 192 195
35. W.-H. Yu, S.C. Yu, Q. Meng, K. Brew, and J.F. Woessner TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix J Biol Chem 275 2000 31226 31232
36. M. Ohgoh, T. Hanada, T. Smith, T. Hashimoto, M. Ueno, and Y. Yamanishi Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis J Neuroimmunol 125 2002 170 178
37. H.D. Hill, and J.G. Straka Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents Anal Biochem 170 1988 203 208
38. A. Lukes, S. Mun-Bryce, M. Lukes, and G.A. Rosenberg Extracellular matrix degradation by metalloproteinases and central nervous system diseases Mol Neurobiol 19 1999 276 284
39. M. Sasaki, S. Seo-Kiryu, R. Kato, S. Kita, and H. Kiyama A disintegrin and metalloprotease with thrombospondin type1 motifs (ADAMTS-1) and IL-1 receptor type 1 mRNAs are simultaneously induced in nerve injured motor neurons Brain Res Mol Brain Res 89 1-2 2001 158 163
40. M. Kashiwagi, J.J. Enghild, C. Gendron, C. Hughes, B. Caterson, and Y. Itoh Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing J Biol Chem 279 2004 10109 10119
41. M.N. Vankemmelbeke, I. Holen, A.G. Wilson, M.Z. Ilic, C.J. Handley, and G.S. Kelner Expression and activity of ADAMTS-5 in synovium Eur J Biochem 268 2001 1259 1268
42. E.M. Muir, K.H. Adcock, D.A. Morgenstern, R. Clayton, N. von Stillfried, and K. Rhodes Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes Brain Res Mol Brain Res 100 1-2 2002 103 117
43. H. Toft-Hansen, R.K. Nuttall, D.R. Edwards, and T. Owens Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis J Immunol 173 2004 5209 5218
44. K. Brew, D. Dinakarpandian, and H. Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 2000 267 283
45. K.P. Langton, M.D. Barker, and N. McKie Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation Biol Chem 273 27 1998 16778 16781
46. D.M. Jaworski, and N. Fager Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) mRNA expression during rat CNS development J Neurosci Res 61 4 2000 396 408